Products Documents
Technical Resources > Reading Room > TechNotes > Volume 8:3
TechNotes 8(3)

Cancer-Related Gene Expression Analysis Made Easy with Ambion's Tumor and Normal Adjacent Tissue RNAs

Whether you want to examine gene expression in individual tumors or screen multiple tumors from a given tissue, Ambion has done the hard work for you. We provide high quality total RNA purified from individual human tumors and the corresponding normal adjacent tissue. This RNA is ready for any downstream application including RT-PCR, gene array analysis, Northern analysis, ribonuclease protection assays, differential display or cloning.

Other FirstChoice™ RNA

Don't forget! Ambion has many other FirstChoice™ RNAs available, including:

  • Normal human tissue total & poly(A) RNA
  • Human cell line total & poly(A) RNA
  • Mouse tissue total & poly(A) RNA
  • Rat tissue total & poly(A) RNA
  • E. coli total RNA

FirstChoice RNAs save time and money while providing access to RNA from tissues that might otherwise be difficult to obtain. FirstChoice poly(A) RNA undergoes three rounds of oligo(dT) selection to minimize the presence of ribosomal RNA, and all FirstChoice RNA is DNase-treated to ensure that it is ready for any downstream application, including RT-PCR. Our unsurpassed Quality Control standards make FirstChoice RNA the highest quality RNA available. See www.ambion.com/fcrna for a list of our entire line of RNA and cDNA products.

Individual Tumor and Normal Adjacent Tissue RNA

FirstChoice™ Human Tumor/Normal Adjacent Tissue RNA pairs include 2 aliquots of 5 µg of total RNA, one isolated from an individual tumor and the other from normal adjacent tissue (NAT) from the same individual. Each product is derived from a single donor and has not been pooled with other RNA, so it can be used for gene expression analysis of a single tumor.

Finest Quality RNA

All of the FirstChoice RNAs are made using the same high quality standards. Each step of the process has been optimized to produce highly pure, intact RNA. To prevent RNA degradation prior to isolation, all tumor/tissue samples are stored in RNAlater™ Tissue Collection:RNA Stabilization Solution. RNAlater quickly permeates tissues and inactivates RNases, so that the RNA is protected immediately upon collection of the tissue, resulting in greater yields of intact RNA. Total RNA is then purified using proprietary techniques that include a rigorous DNase treatment to remove genomic DNA contamination. All Tumor/NAT RNAs are packaged in THE RNA Storage Solution at a convenient, ready-to-use concentration of 0.5 mg/ml. Each of the FirstChoice RNAs is tested for RNase contamination by an overnight incubation at 37ëC followed by agarose gel electrophoresis.


 

Ordering Information

Cat# Product Name Size
AM7224 Human Lung Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7236 Human Colon Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7240 Human Thyroid Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7244 Human Liver Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7248 Human Bladder Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7252 Human Kidney Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7256 Human Ovary Tumor/Normal Tissue RNA 2 x 5 µg
AM7260 Human Testes Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7264 Human Stomach Tumor/Normal Adjacent Tissue RNA 2 x 5 µg
AM7268 Human Lymphoma/Normal Adjacent Tissue RNA 2 x 5 µg
AM7276 Human Cervix Tumor/Normal Adjacent Tissue RNA 2 x 5 µg

 
Home | Products | Technical Resources | What's New | About Us | Contact Us
Advanced Search | Site Map | Privacy | Trademarks/Legal | Web Feedback | Jobs
© Applied Biosystems. All rights reserved.